rvallee
Senior Member (Voting Rights)
Thank you for this. It's especially problematic that the reliability of the review was confirmed as inadequate with no relevant warnings while it is still being cited in clinical practice without those issues being acknowledged, and not in a small way but by NHS trusts themselves.Attached is recent correspondence between me and Hilda, initiated by me after the post-COVID fatigue advice leaflets published and then withdrawn by NHS Trusts, notably Oxford Health.
Frankly that leaflet makes the strongest point, among many others, for the failure of doing an update while not notifying that it's because the review is flawed beyond repair. Really trying to eat their cake and having it too. Which is systemic in BPS research. PACE is the definitive trial that shows GET is "effective" but no one does PACE-style GET anymore so don't worry about it and also other experiments have shown the same (null results but whatever) even though they have the same flaws or worse. There is no self-consistency within any single part of this, and even less so between the parts.
There should be prominent warnings over not only the review page on the Cochrane library but also for every copy used elsewhere. This is fundamental work to a publishing company and although I expect BMJ-type of nonsensical response ("our CMS does not allow us, a publishing company, to do basic publishing things") this is fundamental to their entire business model and frankly arguing otherwise is insulting.
I think Bastian is in a tough spot here where she has no influence over those things but can't admit to the privately-discussed justifications, since they are indefensible. But that makes the whole experiment especially difficult as it gives us every reason to doubt Cochrane's intentions here. Bastian has been open so far but Cochrane continues to be as opaque and unresponsive as ever.
Maybe it's because they still don't believe that our concerns are over substance and legitimate? Too much concern for their colleagues' ego?